skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Fluorine F 18 FEQA (Code C66936)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Fluorine F 18 FEQA

Definition: The anilinoquinazoline derivative FEQA radiolabeled with the positron-emitting radioisotope fluorine F 18 with epidermal growth factor receptor (EGFR) binding and radioisotopic activities. Fluorine F 18 FEQA irreversibly binds to EGFR, allowing imaging of EGFR-positive tumor cells with positron emission tomography (PET).

NCI-GLOSS Definition: A radioactive substance being studied in positron emission tomography (PET) imaging to detect cancer and to monitor the response of some types of cancer to treatment. Fluorine F 18 FEQA attaches to the epidermal growth factor receptor (EGFR) found on the surface of some tumor cells. It is a type of radiopharmaceutical.

Label: Fluorine F 18 FEQA

NCI Thesaurus Code: C66936 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1880812  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Fluorine F 18 FEQA
fluorine F 18 FEQA
N-{4-[(3'- [F-18] Fluoroethylphenyl)amino]-6-quinazolinyl}-acrylamide

External Source Codes: 
PDQ Closed Trial Search ID 534284
PDQ Open Trial Search ID 534284 (check for NCI PDQ open clinical trial info)
UMLS CUI C1880812

Other Properties:
     Name Value (qualifiers indented underneath)
code C66936
Contributing_Source FDA
Legacy_Concept_Name Fluorine_F_18_FEQA
Semantic_Type Indicator, Reagent, or Diagnostic Aid
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom